title: [Vitaprost-forte in the treatment of patients with prostatic adenoma].
abstract: Our study included 50 patients aged 48-67 years with moderate symptoms of prostatic adenoma (PA). Thirty patients received vitaprost-forte in the form of rectal suppositories for 60 days and alpha-adrenoblocker. A positive effect of the drug on PA symptoms and improvement of life quality by IPSS and QoL questionnaires was observed in 93.3% patients. Relief of infravesical obstruction led to a 43% reduction of residual urine. The effect was stable on day 30 after the treatment. Our findings evidence that vitaprost forte can be successfully and safely used in the treatment of PA in combination with alpha-adrenoblockers.
authors.forename: D V
authors.initials: DV
authors.lastname: Shafranov
authors.forename: A A
authors.initials: AA
authors.lastname: Mariupol'skiĭ
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage* / Q000009:adverse effects; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011788:Quality of Life; D013488:Suppositories; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D010455:Peptides; D013488:Suppositories; C524164:Vitaprost